Should I buy or sell Beyond Air stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Beyond Air in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" XAIR shares. View XAIR analyst ratings or view top-rated stocks .

What is Beyond Air's stock price target for 2024?

3 Wall Street analysts have issued 1-year price targets for Beyond Air's shares. Their XAIR share price targets range from $10.00 to $15.00. On average, they expect the company's share price to reach $11.25 in the next twelve months. This suggests a possible upside of 845.4% from the stock's current price. View analysts price targets for XAIR or view top-rated stocks among Wall Street analysts .

How have XAIR shares performed in 2024?

Beyond Air's stock was trading at $1.96 at the start of the year. Since then, XAIR stock has decreased by 39.3% and is now trading at $1.19. View the best growth stocks for 2024 here .

Are investors shorting Beyond Air?

Beyond Air saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 3,500,000 shares, an increase of 23.2% from the March 15th total of 2,840,000 shares. Based on an average daily volume of 299,900 shares, the days-to-cover ratio is presently 11.7 days. View Beyond Air's Short Interest .

When is Beyond Air's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 27th 2024. View our XAIR earnings forecast .

How were Beyond Air's earnings last quarter?

Beyond Air, Inc. (NASDAQ:XAIR) announced its quarterly earnings results on Monday, February, 12th. The company reported ($0.50) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.61) by $0.11. The firm earned $0.39 million during the quarter, compared to the consensus estimate of $0.49 million. During the same period in the prior year, the firm earned ($0.43) earnings per share.

What guidance has Beyond Air issued on next quarter's earnings?

Beyond Air issued an update on its FY 2025 earnings guidance on Tuesday, February, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $12.0 million-$16.0 million.

What other stocks do shareholders of Beyond Air own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Beyond Air investors own include OPKO Health (OPK) , NVIDIA (NVDA) , Pfizer (PFE) , Axsome Therapeutics (AXSM) , BioCryst Pharmaceuticals (BCRX) , Enphase Energy (ENPH) , General Motors (GM) , Livongo Health (LVGO) , Main Street Capital (MAIN) and Ollie's Bargain Outlet (OLLI) .

How do I buy shares of Beyond Air?

Shares of XAIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:XAIR

Beyond Air (XAIR) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free XAIR Stock Alerts

$1.19

-0.09 (-7.03%)

(As of 04/18/2024 ET)

Compare

Today's Range: $1.14
▼
$1.31
50-Day Range: $1.19
▼
$2.15
52-Week Range: $1.14
▼
$6.36

Volume: 604,276 shs
Average Volume: 192,686 shs
Market Capitalization: $42.89 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $11.25

Get Beyond Air alerts:

Beyond Air MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 845.4% Upside
$11.25 Price Target
Short Interest: Bearish
9.71% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.91
Upright™ Environmental Score
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.93) to ($1.57) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.45 out of 5 stars

Medical Sector

254th out of 918 stocks

Surgical & Medical Instruments Industry

30th out of 97 stocks

3.5

Analyst's Opinion

Consensus Rating
Beyond Air has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Beyond Air has received no research coverage in the past 90 days.

0.0

Short Interest

Percentage of Shares Shorted
9.71% of the outstanding shares of Beyond Air have been sold short.
Short Interest Ratio / Days to Cover
Beyond Air has a short interest ratio ("days to cover") of 11.7, which indicates bearish sentiment.
Change versus previous month
Short interest in Beyond Air has recently increased by 23.24%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Beyond Air does not currently pay a dividend.
Dividend Growth
Beyond Air does not have a long track record of dividend growth.

3.5

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Beyond Air has received a 41.63% net impact score from Upright. Beyond Air seems to create the most significant positive value in categories "Jobs", "Physical diseases", and "Creating knowledge". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Medical ventilators", "Clinical research services for the respiratory system", and "Preclinical research services for physical health" products. See details.
Environmental Sustainability
The Environmental Impact score for Beyond Air is -0.91.

2.9

News and Social Media Coverage

News Sentiment
Beyond Air has a news sentiment score of 1.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Beyond Air this week, compared to 1 article on an average week.
Search Interest
7 people have searched for XAIR on MarketBeat in the last 30 days. This is an increase of 40% compared to the previous 30 days.
MarketBeat Follows
Only 3 people have added Beyond Air to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Beyond Air insiders have not sold or bought any company stock.
Percentage Held by Insiders
19.00% of the stock of Beyond Air is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 31.50% of the stock of Beyond Air is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Beyond Air are expected to grow in the coming year, from ($1.93) to ($1.57) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Beyond Air is -0.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Beyond Air is -0.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Beyond Air has a P/B Ratio of 0.85. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Beyond Air Stock (NASDAQ:XAIR)

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

XAIR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

XAIR Stock News Headlines

April 13, 2024 | americanbankingnews.com

Beyond Air, Inc. (NASDAQ:XAIR) Short Interest Update

April 10, 2024 | msn.com

Beyond the Horizon Air and Space Show ends with record number of spectators

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 20, 2024 | markets.businessinsider.com

Beyond Air Prices Direct Offering Of $16 Mln Of Shares, Warrants

March 20, 2024 | globenewswire.com

Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants

March 16, 2024 | yahoo.com

Beyond Paradise star teases a different side to her character in season 2

February 23, 2024 | realmoney.thestreet.com

Will Renewed Nvidia Excitement Lift the Entire Market?

February 20, 2024 | yahoo.com

Bed Bath & Beyond has a new CEO, air quality’s rising impact on real estate and more

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

February 13, 2024 | investing.com

Beyond Air (XAIR) Earnings Dates & Reports

February 13, 2024 | msn.com

Beyond Air, Inc. (NASDAQ:XAIR) Q3 2024 Earnings Call Transcript

February 12, 2024 | benzinga.com

Recap: Beyond Air Q3 Earnings

February 12, 2024 | msn.com

Beyond Air, Inc. (XAIR) Reports Q3 Loss, Misses Revenue Estimates

February 12, 2024 | finance.yahoo.com

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024

February 12, 2024 | finance.yahoo.com

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024

February 9, 2024 | benzinga.com

A Preview Of Beyond Air's Earnings

February 3, 2024 | msn.com

AI model gives air quality forecasts that are similar to weather forecasts

January 18, 2024 | finance.yahoo.com

Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast

December 27, 2023 | msn.com

Medical Device Player Beyond Air's Subsidiary Reveals Encouraging Data From Early-Stage Cancer Study

December 27, 2023 | finance.yahoo.com

Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors

December 23, 2023 | finance.yahoo.com

Beyond Air Independent Director Acquires 102% More Stock

December 22, 2023 | benzinga.com

Beyond Air Stock (NASDAQ:XAIR) Dividends: History, Yield and Dates

December 22, 2023 | finance.yahoo.com

Director Robert Carey Acquires 1,200,000 Shares of Beyond Air Inc (XAIR)

December 21, 2023 | msn.com

Beyond Air CEO buys shares worth about $127k - filing

December 21, 2023 | finance.yahoo.com

Insider Buying: CEO Steven Lisi Acquires 77,775 Shares of Beyond Air Inc

December 19, 2023 | msn.com

Beyond Air director Robert Carey purchases 1.2M common shares

November 29, 2023 | morningstar.com

Beyond Air Inc XAIR

See More Headlines

Receive XAIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beyond Air and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/12/2024
Today: 4/18/2024
Next Earnings (Estimated): 6/27/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:XAIR
CUSIP: N/A
CIK: 1641631
Web: www.beyondair.net
Phone: (516) 665-8200
Fax: N/A
Employees: 98
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $11.25
High Stock Price Target: $15.00
Low Stock Price Target: $10.00
Potential Upside/Downside: +845.4%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($2.13)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-55,820,000.00
Net Margins: N/A
Pretax Margin: -10,288.97%
Return on Equity: -199.90%
Return on Assets: -106.00%

Debt

Debt-to-Equity Ratio: 0.61
Current Ratio: 3.39
Quick Ratio: 3.26

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.40 per share
Price / Book: 0.85

Miscellaneous

Outstanding Shares: 36,040,000
Free Float: 29,192,000
Market Cap: $42.89 million
Optionable: Optionable
Beta: -0.18

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Steven Adam Lisi (Age 53)
CEO & Chairman of the Board
Comp: $650k
Mr. Amir Avniel (Age 50)
Co-Founder, President, Chief Business Officer & Director
Comp: $400k
Mr. Michael A. Gaul (Age 69)
Chief Operating Officer
Comp: $350k
Mr. Douglas Quinton Larson (Age 53)
CFO, Principal Financial Officer & Principal Accounting Officer
Comp: $274.95k
Edward Barger
Head of Investor Relations
Ms. Kori-Ann Taylor
Head of Marketing
Dr. Andrew R. Colin M.D.
Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board
Dr. Jeff Myers M.D. (Age 59)
Ph.D., Chief Medical Officer
Mr. Adam Newman
Corporate Secretary

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

XAIR Stock Analysis - Frequently Asked Questions

Should I buy or sell Beyond Air stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Beyond Air in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" XAIR shares.
View XAIR analyst ratings or view top-rated stocks.
What is Beyond Air's stock price target for 2024?: 3 Wall Street analysts have issued 1-year price targets for Beyond Air's shares. Their XAIR share price targets range from $10.00 to $15.00. On average, they expect the company's share price to reach $11.25 in the next twelve months. This suggests a possible upside of 845.4% from the stock's current price.
View analysts price targets for XAIR or view top-rated stocks among Wall Street analysts.
How have XAIR shares performed in 2024?: Beyond Air's stock was trading at $1.96 at the start of the year. Since then, XAIR stock has decreased by 39.3% and is now trading at $1.19.
View the best growth stocks for 2024 here.
Are investors shorting Beyond Air?: Beyond Air saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 3,500,000 shares, an increase of 23.2% from the March 15th total of 2,840,000 shares. Based on an average daily volume of 299,900 shares, the days-to-cover ratio is presently 11.7 days.
View Beyond Air's Short Interest.
When is Beyond Air's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, June 27th 2024.
View our XAIR earnings forecast.

How were Beyond Air's earnings last quarter?: Beyond Air, Inc. (NASDAQ:XAIR) announced its quarterly earnings results on Monday, February, 12th. The company reported ($0.50) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.61) by $0.11. The firm earned $0.39 million during the quarter, compared to the consensus estimate of $0.49 million. During the same period in the prior year, the firm earned ($0.43) earnings per share.
What guidance has Beyond Air issued on next quarter's earnings?: Beyond Air issued an update on its FY 2025 earnings guidance on Tuesday, February, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $12.0 million-$16.0 million.
What other stocks do shareholders of Beyond Air own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Beyond Air investors own include OPKO Health (OPK), NVIDIA (NVDA), Pfizer (PFE), Axsome Therapeutics (AXSM), BioCryst Pharmaceuticals (BCRX), Enphase Energy (ENPH), General Motors (GM), Livongo Health (LVGO), Main Street Capital (MAIN) and Ollie's Bargain Outlet (OLLI).
How do I buy shares of Beyond Air?: Shares of XAIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:XAIR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Beyond Air (XAIR) Stock Price, News & Analysis

Beyond Air MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Beyond Air Stock (NASDAQ:XAIR)

XAIR Stock Price History

XAIR Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

XAIR Stock Analysis - Frequently Asked Questions

Overall MarketRank^™